ELV

Elevance Health, Inc.

Ticker: ELVFinancialsInsuranceS&P 500
HQ INDIANAPOLIS, INCIK 1156039FY end 12-31Book / share $204.85Shares 219M
Revenue (FY)
$199.13B+12.49%
TTM $201.11B
Op. margin
0.00%
Net income
$5.66B-5.19%
TTM $4.95B
Operating cash
$4.29B-26.14%
TTM $7.46B
Free cash flow
$3.17B-30.27%
TTM $6.29B
Return on equity
12.90%-1.57%
TTM 11.06%
Debt / equity
0.73-0.03%
TTM 0.69
Shares outstanding
224.6M-3.56%
TTM 219.1M

The business

Elevance Health, Inc. (NYSE: ELV) is one of the largest health insurers in the United States, serving approximately 45.2 million medical members through affiliated health plans as of December 31, 2025. The company operates as an independent licensee of the Blue Cross and Blue Shield Association, holding BCBS licenses across multiple states including California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia, and Wisconsin. Elevance Health's website is www.elevancehealth.com.

The company operates through four reportable segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment represents the largest portion of operations, offering comprehensive managed care risk-based plans and administrative services across Individual, Employer Group, Medicaid, Medicare, and Federal Employee Program markets. CarelonRx provides pharmacy services including home delivery, specialty pharmacies, claims adjudication, formulary management, and ambulatory infusion centers to both internal and external customers. Carelon Services integrates physical, behavioral, pharmacy, and social-care capabilities through Carelon Health and Carelon Insights businesses, offering whole-health solutions and analytics-driven services.

Elevance Health generates approximately 32 percent of total consolidated revenues from U.S. government agencies, primarily through Medicare and Medicaid programs. The company operates under recognized brands including Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon. Its competitive positioning is strengthened by exclusive rights to market products under the BCBS brand in significant markets, combined with extensive provider networks, local market expertise, and national scale capabilities.

The company's business model emphasizes value-based care delivery, coordinated care management, and integrated whole-health solutions addressing medical, pharmacy, behavioral health, and social needs. Elevance Health maintains broad and narrow provider networks tailored to different customer segments and employs sophisticated medical management programs, care coordination services, and digital engagement platforms including Sydney Health. The company operates across all 50 states, the District of Columbia, and Puerto Rico through various subsidiaries, positioning it to serve diverse customer needs through local market focus combined with national operational capabilities.

Sector
Financials
Industry
Insurance
HQ
INDIANAPOLIS, IN
FY end
12-31
CIK
1156039
SIC
6324
Financial performance · annual
20132025
$-20.11B$40.22B$100.56B$160.89B$221.22B2013201420152016201720182019202020212022202320242025TTMTTMTTM

Ownership

Who holds Elevance Health, Inc. — across funds, superinvestors and bonds · N-PORT 2026Q2 · 13F 2026-06-30

936
funds hold it
5 of 35
superinvestors hold it
$30.12B
fund-held value
36.1%
of shares held by funds
37
bond issues held by funds

Top fund holders

Fund% of fundValue
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.11%$2.56B
VANGUARD 500 INDEX FUND
VOO · VANGUARD INDEX FUNDS
0.12%$2.08B
VANGUARD WINDSOR II FUND
VWNFX · VANGUARD WINDSOR FUNDS
1.90%$1.24B
iShares Core S&P 500 ETF
IVV · iShares Trust
0.13%$1.16B
Fidelity 500 Index Fund
FXAIX · Fidelity Concord Street Trust
0.13%$1.11B

Superinvestors in Elevance Health, Inc.

Bill NygrenINCREASED +2.7%
Harris Associates (Oakmark)
2.5%
Seth KlarmanUNCHANGED
Baupost Group
9.1%
Ruane CunniffDECREASED -29.4%
Ruane, Cunniff & Goldfarb (Sequoia)
5.9%

Share of each manager's reported 13F portfolio.

Bonds held by funds

Funds report holding 37 issues of Elevance Health, Inc.'s debt, $4.93B at fund-held market value — what funds hold, not the company's debt outstanding. Weighted-average coupon 4.55%, maturing 20262064.

IssueCouponMaturesFundsFund-held
Elevance Health Inc4.750%2030-02-1560$340.95M
ELEVANCE HEALTH5.200%2035-02-1590$320.20M
Elevance Health Inc2.250%2030-05-1565$278.47M
ELEVANCE HEALTH5.000%2036-01-1569$275.02M
ELEVANCE HEALTH5.375%2034-06-1563$249.79M
Elevance Health Inc3.650%2027-12-0169$244.38M
ELEVANCE HEALTH INC4.750%2033-02-1570$240.21M
ELEVANCE HEALTH INC4.101%2028-03-0177$213.20M
Elevance Health Inc5.700%2055-02-1569$201.21M
ELV 2.55 03/15/312.550%2031-03-1567$191.71M

The 10 largest by fund-held value, of 37.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.

Go deeper in your own AI

15 years of statements, narrative and filings — queryable over MCP.

Read ELV's last four 10-Qs: what changed in segment trends, margins and management's narrative?
Run in your AI →

Professionals can also use the built-in AI chat (subscription + your own Anthropic key).

15 years of Elevance Health, Inc.'s financials

Income statement, balance sheet and cash flow across 15 years, every filing with its disclosures, and each number traceable to the filing it came from — free with an account, no card required.

Sign in free